<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A disturbance of the X chromosome inactivation process has been demonstrated in some human <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>In order to study this phenomenon in <z:hpo ids='HP_0001909'>leukemia</z:hpo>, the site of unusually frequent folding in Xq13-q21 was used as a morphological marker </plain></SENT>
<SENT sid="2" pm="."><plain>A total of 858 GTG-banded mitoses from 61 women with different <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematological malignancies</z:e> were analyzed, 35 of them with <z:mpath ids='MPATH_458'>normal</z:mpath> karyotype and 26 with chromosome aberrations </plain></SENT>
<SENT sid="3" pm="."><plain>The folding patterns and the fold percentage remained unchanged in our patients </plain></SENT>
<SENT sid="4" pm="."><plain>Using this marker, X-inactivation could easily be verified in <z:hpo ids='HP_0001909'>leukemia</z:hpo> and related disorders on routine preparations </plain></SENT>
</text></document>